Prostate cancer decisions — 2025

The Board granted earlier effective dates for the grant of service connection for posttraumatic stress disorder with anxiety and depression, migraine headaches, and coronary artery disease with hypertensive heart disease. The claims for an earlier effective date for diabetes mellitus and prostate cancer were denied.

The Board granted service connection for status post prostatectomy due to prostate cancer and erectile dysfunction, resolving all doubt in the Veteran's favor.

The Board remands the claim for service connection for prostate cancer to obtain a VA examination and opinion, including an evaluation of toxic exposure risk activity (TERA) under the PACT Act.

The Board granted a rating of 40 percent, but no higher, for prostate cancer residuals effective September 1, 2024.

The Board granted service connection for hypertension and prostate cancer, both related to in-service herbicide agent exposure at Fort Chaffe.

The Board granted an effective date of August 10, 2022, for a 100 percent disability rating for prostate cancer and lower urinary tract symptoms, as well as special monthly compensation (SMC) at the housebound rate from the same date.

The Board granted the restoration of a 100 percent rating for prostate cancer effective April 1, 2022, and denied service connection for diabetes mellitus, type II. The claims for service connection for major depressive disorder and peripheral neuropathy of the bilateral lower extremities were remanded.

The Board granted a total disability rating based on individual unemployability (TDIU) from August 1, 2022, and also granted special monthly compensation under 38 U.S.C. § 1114(s) and Dependents' Educational Assistance (DEA) benefits beginning the same date.

The Board remands the Veteran's claims for service connection for prostate cancer and an acquired psychiatric disability, to include depression, due to a pre-decisional duty to assist error regarding potential herbicide exposure.

The Board granted service connection for prostate cancer, chronic renal disease, and hypertension due to presumed exposure to contaminated water at Camp Lejeune. Service connection was also granted for depression related to the Veteran's service-connected tinnitus. The claims for service connection for lymphedema, a back condition, gout, a right toe condition, a left ankle condition, diabetes mellitus, bilateral leg clots, bilateral lower extremity neurological conditions, and erectile dysfunction were denied or remanded.

The Board remands the claims for an earlier effective date for service connection for prostate cancer, ED, and SMC based on loss of use of a creative organ due to lack of substantial compliance with prior remand instructions.

The Board dismissed the veteran's appeal for service connection for heart disability, prostate cancer, diabetes mellitus, type II, and peripheral neuropathy due to a lack of jurisdiction.

The Board denied earlier effective dates for the grants of service connection for prostate cancer, DM2, and ED as well as the award of SMC under 38 U.S.C. § 1114(k) because no earlier claim was filed within one year of the enactment of the PACT Act.

The Board remands the case to obtain an addendum opinion regarding the etiology of the Veteran's prostate cancer, specifically whether it is caused or aggravated by exposure to contaminated water at Camp Lejeune.

The Board denied the veteran's claims for service connection for prostate cancer, esophageal cancer, an acquired psychiatric disorder, and hypertension as they were not supported by sufficient evidence of a current disability or a nexus to service.

The Board granted an initial 70 percent disability rating for PTSD from October 27, 2011, to October 12, 2019; a 100 percent disability rating for PTSD from October 13, 2019, to August 2, 2021; and a 10 percent disability rating for headaches effective February 10, 2020.

The Board remands the issue of entitlement to service connection for prostate cancer claimed as due to herbicide exposure for further development, specifically directing that efforts be made to verify the Veteran's alleged in-service exposure through the US Army Records Research Center.

The Board remands the claims for service connection for Parkinson's disease, prostate cancer, bilateral choroidal melanoma, malignant melanoma of the back, and a respiratory disability due to outstanding evidence and duty-to-assist errors.

The Board denied the application to readjudicate a previously denied claim of service connection for lumbosacral strain and degenerative arthritis of the spine, as no new and relevant evidence was submitted. The claims for prostate cancer and bladder disability were remanded for further development.

The Board granted service connection for prostate cancer, which is presumptively linked to the Veteran's exposure to herbicide agents during his service at Takhli Royal Thai Air Force Base in Thailand.